With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Role of MST1 in Non-canonical Hippo Signaling in Rhabdomyosarcoma||Duke University / Lisa Crose, Ph.D.||'A' Award Grants||2014||North Carolina|
|Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth||Duke University / Kyle Walsh, Ph.D.||'A' Award Grants||2014||North Carolina|
|Symptom Patterns during Pediatric Hematopoietic Stem Cell Transplant Recovery||Duke University Medical Center / Cheryl Rodgers, RN, PhD||Nurse Researcher Grants||2014||North Carolina|
|Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL||New York University School of Medicine / Mate Maus, PhD||Young Investigator Grants||2014||New York|
|Identification of Rhabdomyosarcoma Therapies Using an Efficient Mouse and Drosophila Repurposing Screen||Memorial Sloan-Kettering Cancer Center / Mary Baylies, Ph.D.||Reach Grants||2014||New York|
|Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL||Columbia University / Adolfo A. Ferrando, M.D., Ph.D.||Innovation Grants||2014||New York|
|Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics||Hospital for Sick Children / Vijay Ramaswamy, MD||Young Investigator Grants||2014||Ontario|
|Genomic Discovery of Wilms Tumor||Samuel Lunenfeld Research Institute of Mount Sinai Hospital / Rayjean Hung, PhD||Epidemiology Grants||2014||Ontario|
|The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2014||Pennsylvania|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|